liquid chromatography

AI is changing how experiments are designed, executed, and interpreted in early-stage drug discovery.

Over 260 exhibitors and a world-class scientific program will spotlight the latest technologies driving personalized medicine, advanced analytics, and digital transformation in the lab.

Roche scientists developed novel bead technology to automate mass spectrometry, increasing clinician and patient access to this sensitive diagnostic technology.

Achieving higher accuracy and depth in bottom-up proteomics involves navigating a multifaceted process with various steps and challenges.

Slight modifications to glycoproteins reveal critical insights into disease onset, state, and progression, making them a wellspring for biomarker discovery.